D.E. Shaw & Co
VTAE

D.E. Shaw & Co’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

D.E. Shaw & Co’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-36,926
Closed -$245K – 3669
2016
Q1 		$245K Sell
36,926
-166,536
-82% -$1.51M ﹤0.01% 3108
2015
Q4 		$3.68M Buy
203,462
+82,539
+68% +$1.14M 0.01% 1655
2015
Q3 		$1.33M Buy
+120,923
New +$1.28M ﹤0.01% 2406

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co's VTAE Position: Q2 2016 in Review

D.E. Shaw & Co sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2016, closing a stake of 36,926 shares — an estimated $245K sold.

D.E. Shaw & Co first reported a position in VTAE in Q3 2015 and held it in 3 quarters. The position peaked at $3.68M in Q4 2015. 71 funds tracked by Wall St. Rank hold VTAE as of Q2 2016.

  • D.E. Shaw & Co reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 36,926 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2016, an estimated $245K.
  • D.E. Shaw & Co first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2015 and held it in 3 quarters.
  • D.E. Shaw & Co's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $3.68M in Q4 2015.
  • 71 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.